Lech Ignatowicz

Lech Ignatowicz, Ph.D. is the Chairman of Moligo’s board of directors.

Lech is a scientist turned entrepreneur with more than 15 years experience in infectious disease prevention, global health and biotech. Lech focuses his efforts on early-stage ventures where he aims to bring cutting-edge academic discoveries to the “real world”.

He co-founded Biopromic – a point of care diagnostics for tuberculosis and malaria, and he is founding investor and Chief Strategy Officer of Moligo Technologies. In 2017 together with Noushin Emami and Johan Paleovrachas he co-founded Molecular Attraction to develop, implement and scale new mosquito-specific population control methods discovered by Noushin during her academic career.